Mount Sinai Careers
Please enter a valid email.
Unfortunately, our network is not responding. Please try again later.
Your job alert was successfully created.
We are currently focused on inhibitors of the RAS/RAF/MEK/ERKsignaling, a pathway deregulated in a third of human tumors, including the vast majority of melanomas. Our goal is to gain a deeper understanding of oncogenic signaling and use this knowledge to develop mechanism-based therapeutic strategies in cancer. PhD in related field in science